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The mode through which early insults in brain development result in the onset of psychiatric disorders years
after impact become a little less mysterious with the report by Niwa et al. that a transient reduction of the
schizophrenia risk gene DISC1 can alter prefrontal cortex neurochemistry, architecture, and function.From its initial inception as a mainstream
hypothesis (Weinberger, 1987), how neu-
rodevelopmental perturbations can lead
to adult-onset psychiatric disorders has
remained perplexing. With this current
report by Niwa et al. and recent studies
by other laboratories, the phenomenon
has been demystified, and it appears
that transient ontogenetic challenges of
certain spatial and temporal specificity
are sufficient to invoke a disease process.
Development is defined as a state of
change 3 time, with immature systems
in a state of flux prior to achieving homeo-
static stability. Development is sensitive
to genetic and environmental challenges
that can create a new trajectory (Wad-
dington, 1940), which over time, may
result in an allostatic load (McEwen and
Wingfield, 2003) that eventually results in
systemic breakdown—hence the emer-
gence of a disease state, even in the
context of what appears on the surface
to be minor ‘‘cracks’’ in brain architecture
and molecular status.
The findings of Niwa et al. (2010) pre-
sented in this issue of Neuron, were gen-
erated by the application of in utero elec-
troporation (IUEP) to accomplish gene
transfer in the prefrontal cortex (PFC) of
the fetal mouse. The studies extend be-
yond the recent report on the impact of
Disc1developmental disruptions through-
out the brain (Ayhan et al., 2010), probing
instead the relationship between early
and transient (pre/perinatal) nonlethal
gene disruptions within a defined set of
cortical neurons and later (postpubertal)
neurochemical and behavioral dysfunc-tion. This is not a first for examining the
issue of developmental timing and post-
pubertal onset of pathophysiology, but
the unique connection with a replicated
genetic risk factor for schizophrenia, Dis-
rupted-in-Schizophrenia-1 (DISC1), pla-
ces added significance to the findings.
Thus, while the specific mechanisms
that underlie the developmental allostatic
challenges remain a mystery, Niwa’s
group adds to a small but growing dataset
reflecting latent cellular and behavioral
traits resulting from a much earlier and
possibly transient insult (Belforte et al.,
2010; Koshibu and Levitt, 2008; Meyer
et al., 2006; Zuckerman et al., 2003).
From the current study, there is, in some
sense, the frightening thought that one
may never be able to identify signature
patterns of psychiatric disease risk, be-
cause such early changes may go unde-
tected as a result of the restricted and
highly transient nature of the spatial and
temporal insults.
As the authors note, IUEP is useful
for developing animal models that mimic
(endo)phenotypic features of neurodeve-
lomental disorders that emerge in child-
hood or even after puberty. Furthermore,
these endophenotypes are expressed be-
yond strictly defined clinical populations,
extending to those who are defined as
neurotypical, but who may exhibit deficits
in restricted domains. Therefore, these
models are useful in probing heteroge-
neity of numerous behaviors, including
social-emotional affect, higher-order cog-
nitive functions such as learning and
memory, executive functioning, and evenNeuron 65,empathy. There hasbeenaparallel growth
of studies describing genetic and experi-
ence-dependent correlations of disrup-
ted, clinically relevant endophenotypes.
The experimental strategies used by
Niwa et al. begin to define more specifi-
cally correlations within the context of
specific circuits that may be key in under-
standing the molecular mechanisms that
drive the adaptive neurodevelopmental
changes underlying late-onset clinical
behavior.
The authors transiently reduced Disc1
expression selectively in pyramidal neu-
rons of the PFC. Abnormalities in the
development of pyramidal dendritic mor-
phology preceded decreases in extracel-
lular dopamine (DA) and reductions in
tyrosine hydroxylase (TH) and parvalbu-
min immunoreactivity following Disc1
reduction. These changes then normalize
over time. As a result of themethodologies
employed, the impactwas limited spatially
toPFCprojection neurons. Though it is not
possible to examine all parameters of PFC
circuitry, the described changes to major
neurotransmitter systems were limited to
the biogenic amine DA; norepinephrine,
serotonin, and glutamate content were
unchanged. The authors further challenge
the system, as might occur in clinically at-
risk populations, and show that following
Disc1 knockdown, there are adaptive
changes in methamphetamine-induced
DA release, but there is no impact on
dopamine D1 (Drd1) and D2 (Drd2) re-
ceptor expression. Remarkably, following
Disc1 normalization over time, behavioral
dysfunctions emerged only after puberty,February 25, 2010 ª2010 Elsevier Inc. 437
Figure 1. Early, Transient Reduction of Disc1 May Serve as
an Exemplar of a More General Phenomenon that Underlies
Neurodevelopmentally-Based Psychiatric Disorders
Genetic or environmental disruptions of key circuits during development
create an allostatic load that alters (red) typical developmental trajectory
(black). These early changes can lead to subtle alterations in developing
circuitry and neurochemistry. The neural components that underlie disorder
pathophysiology ultimately are vulnerable to later-occurring stressors. These,
in turn, differentially diffract the course of maturation, leading to alterations in
postpubertal behavior output. These later stressors also can act on typically
developing pathways to generate neurotypical heterogeneity in which
variability in endophenotypes emerge. The dotted black line indicates that
intervention during sensitive periods, prior to clinical diagnosis, may be able
to reroute developmental trajectory toward neurotypical functioning.
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Previewsincluding deficits in schi-
zophrenia-relevant behaviors,
such as prepulse inhibition
(PPI) and memory consoli-
dation. Niwa et al. demon-
strated functional relevance
of the transient neurochemical
changes by rescuing the
behavioral disruptions through
increasing extracellular DA
levels with clozapine, a D2
receptor antagonist.
Niwa et al. do not address
the mechanisms through
which transient reduction of
Disc1 impact DA signaling.
Disc1 interacts with proteins
that modulate cell motility
and growth (e.g., NUDEL,
Dab1) (Kamiya et al., 2005)
andcAMP-phosphodiesterase
signaling (Millar et al., 2005).
The connection to pyramidal
cell morphology is evident,
but the link to the behavioral
and neurochemical pheno-
types is not clear. The data
do indicate that the impact
on DA signaling is quite selec-tive. Despite significant decreases in both
dopamine and tyrosine hydroxylase,
surprisingly no changes in Drd1 or Drd2
expression in the PFC were found. The
complexity of cellular and behavioral re-
sponses to dopaminergic challenge
following Disc1 knockdown begs the
question of whether these receptors are
functionally normal, a parameter that is
key to understanding mechanistically the
adaptive changes that PFC circuitry un-
dergoes following Disc1 knockdown. The
rescue of PPI intimates that clozapine
can block the dopamine D2 receptor
following Disc1 reduction, but the effects
of quinpirole are blunted. These data, in
combination with the increased DA
release following methamphetamine,
raise the possibility that alterations in the
dopamine transporter (DAT) might also
occur following Disc1 disruption, altering
synaptic function. Similarly, the status of
the dopamine D1 receptor was not exam-
ined following Disc1 disruption. Other
experimental paradigms that influence
dopaminergic development, such as
temporally limited prenatal cocaine expo-
sure, have generated significant changes
in membrane trafficking of the dopamine438 Neuron 65, February 25, 2010 ª2010 ElsD1 receptor (Stanwood and Levitt, 2007).
If either dopamine D1 or D2 receptor traf-
ficking is altered following Disc1 reduc-
tion, this also could lead to dramatic
changes in physiological signaling in
response to either dopaminergic chal-
lenge, or even changes in circuit-specific
physiological activity. Moreover, while no
differences were found at P56 (adoles-
cence) in expression of either Drd1 or
Drd2, examination in adulthood of DA
integrity is important, as this prefrontal
input exhibits changes through puberty
(Rosenberg and Lewis, 1995).
Niwa et al. examine other circuit param-
eters known to be targets in schizo-
phrenia, such as parvalbumin (PV) immu-
noreactivity. IUEP-induced reduction of
Disc1 prenatally did result in reductions
of PV, but there was no further character-
ization of this subpopulation of interneu-
rons, which differ in density between
rodent and primate (Hof et al., 1999). Par-
valbumin interneurons are fast-spiking
nonadapting neurons that also coexpress
the dopamine D1 receptor (Glausier et al.,
2009; Le Moine and Gaspar, 1998).
Further characterization of the function
of these interneurons following Disc1evier Inc.disruption is needed, as dis-
ruptions in dopamine sig-
naling will most likely effect
these interneurons and all
the primary targeted pyra-
midal neurons.
Monoamines are neuromo-
dulators in adult systems and
appear to play similar roles
during development. Insults
through direct or indirect ma-
nipulations lead to subtle, yet
functionally robust disrup-
tions in cell signaling, circuit
development, and behaviors.
The similarities in the long-
term consequences between
the Niwa et al. report of tran-
sient genetic disruption and
a different experimental para-
digm, temporally limited
prenatal cocaine exposure
(an environmental disruption),
are striking. Both experi-
mental paradigms result in
subtle but permanent long-
term disruptions in cellular
and behavioral phenotypes
(Lidow, 1998; Morrow et al.,2005; Thompson et al., 2005). Interest-
ingly, neither experimental paradigm
leads to gross changes in architecture.
However, when the two experimental
groups are challenged (by time, behav-
ioral probes of cognitive functioning, or
stress), significant disruptions in cellular
signaling and behavioral functions
emerge.
Studies of functional relevance natu-
rally lead to studies that will dig deeper
mechanistically, and Niwa et al. accom-
plish this. For example, while intriguing
that the cellular and behavioral pheno-
types do not occur until P48–P56, the trig-
gers that generate the emergence of
pathophysiology, which is clearly clini-
cally relevant, are unknown. Thus, similar
to the black-box theory of learning, the
mechanism responsible for translating
the input (Disc1 reduction) into the output
(altered postpubertal cellular and behav-
ioral phenotype) remains elusive. The
most obvious correlate in the current
model is puberty, which may serve to
diffract allosterically loaded neurodeve-
lopmental trajectories toward pathophys-
iological functions (Figure 1). A direct
manipulation of the timing of puberty by
Neuron
Previewsdelaying or speeding up onset would be
an important experimental twist. Similarly,
it would also be interesting to probe
whether other subtle stressors (immune
challenge, brief exposure to stress, or an
environmental toxin) could trigger col-
lapse in a similar way. Detailed studies
also will need to elucidate the functional
state of each of the components of the
dopamine-signaling pathway following
transient pre/perinatal reductions of
Disc1. Electrophysiology studies could
directly address whether dopamine D1
and D2 receptors are responding nor-
mally to both dopaminergic and PFC
circuit-specific challenges. Based on the
morphological and neurochemical re-
sults, pyramidal and parvalbumin inter-
neuron functions, dopamine transporter
activity, and receptor trafficking should
be examined directly. As the authors
note, it also is important to determine
how transiently decreasing Disc1 leads
to alterations in dendritic morphology of
pyramidal neurons, which further disrupts
the mesocortical DA projections, ulti-
mately creating an allostatic load on the
PFC that causes altered behavioral
phenotypes.
Finally, this report illustrates the neces-
sity of examining the progression of
prenatal disruptions in a temporal fashion.
Furthermore, these results highlight thepossibility of long-lasting consequences
bysubtlyandselectivelydisturbingacircuit
early in its assembly. Underlying mecha-
nisms driving this phenomenon together
with the development of novel strategies
for buffering the impactofdevelopmentally
induced allostatic load have the capacity
to generate novel clinical prevention and
intervention strategies prior to disease
onset—a noble goal that is occurring
more frequently through the translation of
basic neurobiological studies.REFERENCES
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Recent research has introduced the major histocompatibility complex class I (MHCI) genes as unexpected
players in structural and synaptic plasticity in the central nervous system. In this issue of Neuron, Xu et al.
redirect current theory by providing strong evidence for the inner retina as a site of action of MHCI proteins
in retinogeniculate refinement.Although very well studied for their role
in antigen presentation in the immune
system, major histocompatibility complexclass I (MHCI) genes have only recently
been highlighted for their role in develop-
mental plasticity (reviewed in Boulanger,2009). Corriveau et al. (1998) first demon-
strated the expression of MHCI proteins
in the normal brain and revealed that theirFebruary 25, 2010 ª2010 Elsevier Inc. 439
